Senate Confirms Monica Bertagnolli as Next NIH Director Vote was 62-36 in favor of the current National Cancer Institute director Nov 07, 2023
FDA Panel Backs High-Risk Designation for Salvaged Blood Irradiators With Class III designation, sponsors would have to prove safety, efficacy with randomized trials Nov 07, 2023
T-DXd Tied to Encouraging Survival in HER2-Expressing Gyn Cancers More responses, longer OS in subset with the highest levels of HER2 expression Nov 07, 2023
Sexual Health Suffered After Radical Hysterectomy for Early Cervical Cancer Compared with simple hysterectomy, analysis shows more sexual toxicities, worse quality of life Nov 07, 2023
Lung Cancer Survival High at 20 Years With Screen-Detected Tumors After two decades, lung cancer-specific survival remained at 81% in I-ELCAP program Nov 07, 2023
Mixed Results for Tiragolumab/Atezolizumab Combo in PD-L1+ Recurrent Cervical Cancer Overall response beats historical benchmark, but misses significance target Nov 06, 2023
RAF/MEK and FAK Inhibitor Combo Effective in Low-Grade Serous Ovarian Cancer Impressive overall response rate with avutometinib-defactinib in RAMP 201 trial Nov 05, 2023
Maintenance Selinexor May Boost PFS in TP53 Wild-Type Advanced Endometrial Cancer Particularly strong PFS signal seen in patients that were mismatch repair proficient Nov 05, 2023
Adding Atezolizumab Improves Survival in Advanced Cervical Cancer Trial confirms the role of first-line checkpoint inhibition in metastatic or recurrent disease Nov 03, 2023
Evidence of Safety, Efficacy for Salvaged Blood Irradiators Lacking, FDA Staff Say Devices are aimed at preventing metastasis during surgery Nov 03, 2023
Wearables as Cancer Monitors; No China Price Break; Cancer Mystery in Appalachia News, features, and commentary about cancer-related issues Nov 03, 2023
Transitioning Cancer Survivors Away From Oncologic Care It's time for a new model of care Nov 03, 2023
False-Positive Mammograms May Indicate Higher Breast Cancer Risk in the Future Swedish cohort study shows a 61% increased risk over 20 years Nov 02, 2023
Years of Progressing Facial Numbness and Deteriorating Vision Drives Diagnosis Suspect perineural recurrence of cutaneous squamous cell carcinoma, experts urge Nov 02, 2023
Lambert-Eaton Myasthenic Syndrome Underdiagnosed Alongside SCLC in the U.S. Findings suggest patients with SCLC are not screened for LEMS, despite their association Nov 02, 2023
ACS: Millions More Should Get Lung Cancer Screening Notably, new recommendations say it doesn't matter when a person quit smoking Nov 01, 2023
Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPC Grade 3 or higher neutropenia, neutropenic complications reduced by 12-fold Nov 01, 2023
Potential Cure for Sickle Cell Clears Hurdle for Approval FDA advisors suggest the benefits of gene therapy outweigh risks of off-target editing Oct 31, 2023
Personalized Intervention Helps CRC Screening Decisions for Older Adults Patients receiving intervention were less likely to undergo screening if benefits were low Oct 31, 2023
The Exciting Potential of Antibody-Drug Conjugates in Lung Cancer Roy Herbst, MD, PhD, leads a discussion on ADCs targeting TROP2, HER2, and HER3 Oct 30, 2023 video
FDA Reviewers Question Safety of Sickle Cell Gene Therapy Efficacy results "strongly positive," but unintended off-target effects a question Oct 30, 2023
FDA OKs First Drug for Nasopharyngeal Carcinoma Toripalimab approved in combination with first-line chemo, and as monotherapy after progression Oct 30, 2023
Wegovy and Thyroid Cancer; Maine Shooter's Mental Health; 469 Heat Deaths Health news and commentary from around the Web gathered by Â鶹´«Ã½ staff Oct 30, 2023
Chinese Compound for MI?; Knee Pain Management Also in TTHealthWatch: a new colorectal cancer screening test Oct 28, 2023 podcast
Soap to Fight Skin Cancer; $1,000 Early Cancer Detection Test; FDA Approval in MDS News, features, and commentary about cancer-related issues Oct 27, 2023
Neoadjuvant Cemiplimab Shows Potential as an Option for Cutaneous SCC Follow-up results from phase II study show 12-month EFS rate of 89% in stage II-IV disease Oct 25, 2023
Radionuclide Therapy Tops AR-Pathway Inhibitor Switch for mCRPC Time to radiographic progression doubled with 177Lu-PSMA-617 Oct 25, 2023
New Options Challenge Standard Treatments in EGFR-Mutant NSCLC Amivantamab-based regimens improved oncologic outcomes, but with more side effects Oct 25, 2023
Novel Stool RNA Test More Sensitive for Detecting Colon Cancer Versus FIT ColoSense test outperforms fecal immunochemical testing in phase III trial Oct 25, 2023
ALK Inhibitor Outperforms Adjuvant Chemotherapy for Resected Lung Cancer Adjuvant alectinib reduces disease-free survival hazard by 76% Oct 24, 2023
Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers Still some unanswered questions about benefit over other drug regimens, expert says Oct 24, 2023
Randomized Trial Backs HIF-2a Inhibition in Advanced RCC After immunotherapy-TKI failure, belzutifan produces better outcomes versus everolimus Oct 24, 2023
More Data Support Adding Immunotherapy to Chemo in Advanced Endometrial Cancer PFS doubled and OS improved, driven by mismatch repair-deficient disease Oct 23, 2023
Antibody-Drug Conjugate Boosts Survival in Recurrent/Metastatic Cervical Cancer Tisotumab vedotin reduced risk of death by 30% compared with chemotherapy Oct 23, 2023
Targeting KRAS in NSCLC: Recent Progress and New Approaches Roy Herbst, MD, PhD, leads a discussion on current and emerging treatments available Oct 23, 2023 video
Targeted Combination Wins in KRAS-Positive Metastatic Colorectal Cancer Standard dose of sotorasib plus panitumumab reduced risk of progression by 51% vs standard care Oct 23, 2023
Is It a Sports Injury, or Something More Serious? Osteoscarcomas can present to any clinical setting, pediatric researcher says Oct 23, 2023
New First-Line Standard for Lung Cancers With EGFR Exon 20 Insertions Adding amivantamab to chemotherapy improved PFS, induced more rapid and durable responses Oct 23, 2023
'Practice-Changing' Data in Locally Advanced Cervical Cancer Strategies involving immunotherapy, induction chemo move the needle for first time in decades Oct 23, 2023
RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLC Two randomized studies demonstrate significantly improved PFS against standard regimens Oct 22, 2023
